Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AYTU
#4555
Aytu BioPharma, Inc. - Common Stock
2.2
2
USD
+0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.91%
Monthly Change
+0.91%
6 month change
-19.27%
Year Change
+2.30%
Previous Close
2.2
0
Open
2.2
2
Low
2.2
2
High
2.2
2
Volume
1
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
AYTU
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
-618 K
3.67 M
-4.18 M
1.68 M
Cash from investing activities
0
-17 K
0
-3.03 M
Cash from financing activities
2.3 M
-6.26 M
872 K
9.9 M
Free cash flow
-618 K
3.67 M
-4.18 M
1.68 M
News
Aytu BioPharma, Inc. (AYTU) Q3 2026 Earnings Call Transcript
Aytu BioPharma, Inc. (AYTU) Reports Q3 Loss, Tops Revenue Estimates
Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript
Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates
Earnings call transcript: Aytu BioPharma Q2 2026 sees revenue dip, stock falls
New Strong Sell Stocks for February 2nd
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day - Slideshow (NASDAQ:AYTU) 2026-01-20
Aytu launches EXXUA, first selective 5-HT1A agonist for depression
Aytu BioPharma stock rises after commercial launch of depression drug EXXUA